Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
05/2004
05/06/2004EP1414801A1 Arylamines for the treatment of conditions associated with gsk-3
05/06/2004EP1414790A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments
05/06/2004EP1414788A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
05/06/2004EP1414787A1 New derivatives of substituted anilines with herbicidal activity
05/06/2004EP1414460A1 Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor
05/06/2004EP1307441B1 1,3-dioxolanes with antitussive activity
05/06/2004EP1268407B1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
05/06/2004EP0960106B1 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4)
05/06/2004CA2501438A1 Improvement in the storage stability of photoinitiators
05/05/2004CN1494532A New asymmetric process for preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
05/05/2004CN1494528A Benzophenones as inhibitors of reverse transcriptase
05/05/2004CN1494420A Compounds and compositions for delivering active agents
05/05/2004CN1493568A Roxatiding bismuth citrate and its preparation method and use
05/05/2004CN1493567A Methyl morpholine oxide dilute solution active carbon adsorption concentration purification method
05/05/2004CN1148349C N-substituted-N'-substituted urea derivative and use thereof as TNF-Alpha production inhibitor
05/05/2004CN1148346C Hydrazine derivs.
05/04/2004US6730786 Process for the preparation of pyrazolopyrimidinones
05/04/2004US6730784 As therapeutic agents for autoimmune diseases such as rheumatoid arthritis
05/04/2004US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants
05/04/2004US6730671 Compounds useful as reversible inhibitors of cathespin S
04/2004
04/29/2004WO2004035556A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
04/29/2004WO2004035534A2 Novel compounds having a dopaminergic and/or serotoninergic activity
04/29/2004WO2004035525A1 Inhibitors of histone deacetylase
04/29/2004WO2004035521A1 Bis-alkylbenzylamines
04/29/2004WO2003086282A3 Nitric oxide donors, compositions and methods of use
04/29/2004WO2003045919A3 Process for the synthesis of amine ethers from secondary amino oxides and uses
04/29/2004WO2003009807A3 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
04/29/2004WO2002102787A3 Novel sulfonic acid derivatives
04/29/2004WO2002083842A9 Small molecule inhibitors of secretion of proteins encoded by are-mrnas
04/29/2004US20040083447 1-Phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands
04/29/2004US20040082786 Piperazine based inhibitors of factor xa
04/29/2004US20040082779 Melanocortin-4 receptor binding compounds and methods of use thereof
04/29/2004US20040082642 Novel estrogen receptor ligands and method III
04/29/2004US20040082628 Acylated arylcycloalkylamines and their use as pharmaceuticals
04/29/2004US20040082625 Osteoporosis, bone disorders
04/29/2004US20040082617 Sulphones which modulate the action of gamma secretase
04/29/2004US20040082595 Antiproliferative agents; antitumor agents; cyclin-dependent kinase inhibitor
04/29/2004US20040082569 Novel substituted amides, their preparation and use
04/29/2004US20040082547 Prevent thrombosis; anticholesterol agents; cardiovascular disorders; anticancer agents
04/29/2004US20040081620 Measurement anticoagulant
04/29/2004DE10248925A1 Neue Verbindungen mit dopaminerger und/oder serotoninerger Aktivität New connections with dopaminergic and / or serotonergic activity
04/29/2004CA2502249A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
04/29/2004CA2501265A1 Inhibitors of histone deacetylase
04/28/2004EP1413307A1 Therapeutically active levorotatory and dextrorotatory 1-(4-chlorophenyl)phenylmethyl piperazines
04/28/2004EP1412349A2 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists
04/28/2004EP1412335A2 ENANTIOSELECTIVE TRANSFORMATION OF $g(a), $g(b)-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS
04/28/2004EP1412325A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
04/28/2004EP1412324A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
04/28/2004EP1412321A2 Perfluoroalkyl-substituted amines, acids, amino acids and thioether acids
04/28/2004EP1412082A1 Method for hydrogenating organic compounds by means of ru/sio2 catalysts
04/28/2004EP1411922A1 Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
04/28/2004EP1294682B1 Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
04/28/2004EP1263718B1 Novel use of phenylheteroalkylamine derivatives
04/28/2004EP1263714B1 Novel phenylheteroalkylamine derivatives
04/28/2004EP1200384B1 2-alkyl-5-halogen-pent-4-ene carboxylic acids and their production
04/28/2004EP1154983B1 Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
04/28/2004CN1147483C Adamantane derivatives
04/28/2004CN1147294C Pentafluorobenzenesulfonamides and analogs
04/27/2004US6727255 Brain, nervous system and psychological disorders
04/27/2004US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases
04/22/2004WO2004033441A1 Antibacterial agents
04/22/2004WO2004033426A2 Heteroaryl propyl-piperazines and heteroaryl propyl-piperidines serving as dopaminergic and serotoninergic agents
04/22/2004WO2004033415A1 Nitroaniline-based alkylating agents and their use as prodrugs
04/22/2004WO2004032930A1 Method of treatment for cancer
04/22/2004WO2003082263A8 Sulfamic acids as inhibitors of human cytoplasmic protein tyrosine phosphatases
04/22/2004WO2002094794A8 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
04/22/2004WO2000061134A9 Antimicrobial agents
04/22/2004US20040077867 Amine compounds, their production and use
04/22/2004US20040077861 Asymmetric addition of organometallic compounds to chiral sulfinimine to give adducts in predominantly one diastereomer can subsequently be transferred into pure enantiomers of by cleavage of the chiral auxilliary
04/22/2004US20040077857 Method of producting n-substituted 2,6-dialkyl morpholines
04/22/2004US20040077729 2-,N-(Diphenyl)-propionamide derivatives as anticoagulants
04/22/2004US20040077716 Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use
04/22/2004US20040077654 Anticholesterol agents; cardiovascular disorders
04/22/2004US20040077628 Melanin-concentrating hormone antagonist
04/22/2004US20040077502 Stable ethylene inhibiting compounds and methods for their preparation
04/22/2004US20040074016 Cationic aminodianthraquinones, use, dyeing compositions containing them and methods of dyeing
04/21/2004EP1411049A1 Estrogen Agonists/Antagonists
04/21/2004EP1409468A2 Guanidinobenzamides as mc4-r agonists
04/21/2004EP1409467A1 Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors
04/21/2004EP1409466A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
04/21/2004EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
04/21/2004EP1409440A1 A method to inhibit ethylene responses in plants
04/21/2004EP1409080A1 Medicament inhibiting sodium/calcium exchange system
04/21/2004EP1408986A2 Proteomimetic compounds and methods
04/21/2004EP1296946B1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
04/21/2004EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
04/21/2004CN1491222A Piperidinee derivatives as neurokinin/antagonists
04/21/2004CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical
04/21/2004CN1491207A Acylated indanyl amines and their use as pharmaceuticals
04/21/2004CN1490315A Synthesis of roxatidine acetate
04/21/2004CN1146552C Azulene hydroxamic acid derivatives as metalloprotein inhibitors
04/21/2004CN1146536C Cycloethylene derivatives
04/20/2004USRE38506 Potent inducers of terminal differentiation and methods of use thereof
04/20/2004US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
04/20/2004US6723730 Capsaicin receptor ligands
04/20/2004US6723719 Dysmenorrhoea, benign prostatic hyperplasia (bph), bladder outlet obstruction, incontinence, agina, congestive heart failure, atherosclerosis; hypotensive and antiallergen agents
04/20/2004US6723717 Sulfur-containing thyroxane derivatives and their use as hair growth promotors
04/20/2004CA2215585C Practical synthesis of urea derivatives
04/20/2004CA2060580C Ammonium salt of an alkenylsuccinic half-amide and the use thereof as corrosion inhibitor in oil and/or gas production technology
04/15/2004WO2004031139A1 Cyclohexyl sulphones as gamma-secretase inhibitors